PLS hits record as lithium rebound makes Pilgangoora leverage hard to ignore

PLS hits record as lithium rebound makes Pilgangoora leverage hard to ignore

May 12, 2026

Sydney, May 13, 2026, 05:10 AEST

  • PLS finished Tuesday’s session at A$6.50, a gain of 3.5%. The stock hit A$6.59 at its peak, with 32.14 million shares changing hands—well ahead of its recent average. Google
  • Commodities were in the driver’s seat here. Chinese lithium carbonate futures climbed 1.7% to 205,680 yuan a tonne, while names like Liontown and IGO followed suit with gains. Market Index
  • Bulls are betting on operating leverage if lithium prices keep climbing. The bears? They’re calling it a crowded, jumpy trade—especially after PLS’s sharp run-up from last year’s low. Intelligent Investor

PLS Group Limited, which trades on the ASX and was previously Pilbara Minerals, finished Tuesday’s session at A$6.50—22 cents higher. Shares touched A$6.59 intraday, matching their 52-week high per Google Finance data, before slipping back by the close. The ASX has closed at the dateline; these figures reflect the most recent cash-session. Google

The answer jumped out on the commodities screen. Chinese lithium carbonate futures gained 1.7% early, hitting 205,680 yuan a tonne. That puts prices up roughly 9% over five weeks, the highest since August 2023. For PLS, this is key. Their main product? Spodumene concentrate — crushed rock loaded with lithium, which gets turned into battery chemicals. Market Index

Lithium names jumped across the board, not just one outlier. Liontown picked up 6.3%, IGO climbed 5.0% in early afternoon, Mineral Resources joined the move. Core Lithium trailed, a sign that the rally wasn’t indiscriminate—investors weighed size and balance sheet. Market Index

PLS stands out among local players for its exposure to lithium prices. The company’s Pilgangoora site in Western Australia—fully owned, and touted by PLS as the world’s largest independent hard-rock lithium operation—accounts for roughly 8% of global lithium supply. Production capacity could hit 1 million tonnes of spodumene concentrate annually once the P1000 expansion is complete. PLS

The latest company announcement landed as little more than register chatter rather than substantial news on output. Morgan Stanley and MUFG have shown up in recent substantial-holder filings—those go to investors holding at least a 5% voting stake. That’s likely fueling the spotlight on the stock. Still, it leaves tonnes, costs, and realized pricing untouched. Intelligent Investor

Bulls have their case. In its March-quarter update, PLS posted record spodumene concentrate output—232,436 dry metric tons, or dmt, which leaves out water weight. According to Reuters, that’s an 86% jump from the year before. Unit operating costs? Down 11% from the previous quarter to A$520 per metric ton. The company is sticking with its FY2026 output target, holding the range at 820,000 to 870,000 tonnes. Reuters

RBC Capital’s Kaan Peker described the quarter as “a clear beat,” pointing to better-than-expected production numbers and costs coming in lower. CEO Dale Henderson, in comments to Reuters, noted “deepening and broadening demand” for lithium, from stationary batteries to electric trucks. Reuters

Bears push back hard: PLS still has to take whatever price the market gives it, with revenue tied to prevailing rates, not something it sets. And there’s more—according to that same Reuters report, unit costs are likely heading up this quarter, thanks to expenses tied to restarting Ngungaju. Not a small issue, considering the stock’s already rallied from its A$1.14 low on June 3, 2025, all the way to A$6.50. Reuters

Management’s message has stayed cautious. PLS has signed off on restarting the Ngungaju plant, which can turn out about 200,000 tonnes a year, aiming for production to kick off again in July 2026. Henderson described the move as part of a “through-the-cycle strategy” after the slump. As for the P2000 feasibility study—meant to push Pilgangoora’s capacity up to around 2.0 million tonnes annually—it’s still on track for the December quarter of 2026, though it’s waiting on a final investment decision. PLS

The share-price action isn’t just about sentiment—there’s a capital structure angle too. In April, PLS wrapped up a US$600 million senior unsecured notes deal at 6.875% due 2031. Part of those funds went to pay down a drawn revolving credit facility, which was then halved from A$1 billion to A$500 million. On paper, that frees up some room. But now there’s a locked-in debt cost sitting in the accounts, just as the market is pricing in growth optionality. PLS

The mid-stream project’s another wrinkle. PLS has kicked off commissioning on a demonstration plant, lined up as much as A$38.1 million in grant money from ARENA, and inked an offtake agreement with Ronbay for lithium phosphate. Henderson described this as a “disciplined validation and optimisation phase” — accurate enough, since what they’ve got is optionality, not evidence of a fatter-margin business just yet. PLS

Tuesday’s jump made sense, but hardly screamed safety. Lithium prices jolted investors into rethinking PLS’s idle capacity, scale, and downstream plays—everything got repriced in one shot. The risk? It’s right there: with shares racing this far from last year’s lows, the commodity price needs to keep carrying the load.

Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Stock Market Today

  • Atlas Arteria Shares Slide Below IFM's A$5.10 Bid as Takeover Looms
    June 26, 2026, 3:42 PM EDT. Atlas Arteria (ASX: ALX) shares closed at A$5.08 on June 26, just below IFM Global Infrastructure Fund's A$5.10 per share cash offer, reflecting a 0.4% discount. IFM's bid entity, Diamond Infraco, holds 50.99% of voting rights, triggering an automatic extension of the offer deadline to July 7. Despite Atlas' board reviewing the proposal and targeting distributions of at least 60 cents per security, shares trade below independent expert valuations of A$5.39 to A$6.20. Analysts at Citi maintain a neutral stance with a A$5.10 target price, acknowledging near-term dividend boosts but pointing to long-term payout risks. Morningstar advises shareholders to accept IFM's bid, which offers a premium to pre-bid prices, highlighting market focus on liquidity amid nearly double average volume traded.